Shelly and Wayne chat with Martin Hahn, Global Regulatory Partner at Hogan Lovells, and Tony Pavel, Partner at Keller and Heckman. You’ll hear their thoughts on global food supply chain vulnerabilities and how FDA is monitoring them; how U.S. tariffs on imported food products influence the availability and safety oversight of essential goods like formula or medical nutrition; how FDA is working with international partners to improve coordination and transparency; FDA measures to ensure a more resilient and responsive infant formula supply; and much more.

In our Headlines segment, Shelly and Wayne delve into these major developments:

FDA announces expanded use of unannounced inspections at foreign manufacturing facilities

President Trump signs an executive order that aims to reduce drug costs by basing payments for certain medicines on their prices in other countries

Pharma: FDA Commissioner Dr. Marty Makary says layoffs won’t hinder the agency’s target dates for drug reviews

Devices: Two U.S. Senators introduce legislation encouraging the use of AI-enabled medical devices

Food: HHS, FDA announce plans to phase out synthetic dyes in nation’s food supply

Cosmetics: ICCS shares case studies and mock dossiers as examples of how new approach methodologies can be utilized

In our Resource Links segment, we list key documents in our four core areas. To view these links, subscribe, or find out more information about our podcast, visit FDAWatch.net.

Want to be a sponsor, marketing partner, or guest, or provide feedback on the podcast? Email us at info@fdawatch.net.

Music by Dvir Silver from Pixabay.